Cosmo Pharmaceuticals Sa Stock Filter Stocks by Fundamentals
COPN Stock | CHF 62.70 0.50 0.79% |
COSMO Pharmaceuticals SA fundamentals help investors to digest information that contributes to COSMO Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of COSMO Stock. The fundamental analysis module provides a way to measure COSMO Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMO Pharmaceuticals stock.
COSMO |
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
COSMO Fundamentals
Return On Equity | 0.0841 | |||
Return On Asset | 0.0181 | |||
Profit Margin | 0.45 % | |||
Operating Margin | 0.25 % | |||
Current Valuation | 960.99 M | |||
Shares Outstanding | 16.38 M | |||
Shares Owned By Insiders | 47.28 % | |||
Shares Owned By Institutions | 11.80 % | |||
Price To Earning | 95.06 X | |||
Price To Book | 2.21 X | |||
Price To Sales | 12.95 X | |||
Revenue | 65.07 M | |||
Gross Profit | 32.1 M | |||
EBITDA | 40.36 M | |||
Net Income | 21.67 M | |||
Cash And Equivalents | 217.97 M | |||
Cash Per Share | 14.53 X | |||
Total Debt | 169.03 M | |||
Debt To Equity | 35.50 % | |||
Current Ratio | 24.38 X | |||
Book Value Per Share | 28.23 X | |||
Cash Flow From Operations | 12.61 M | |||
Earnings Per Share | 2.13 X | |||
Target Price | 86.03 | |||
Number Of Employees | 292 | |||
Beta | 1.07 | |||
Market Capitalization | 1.12 B | |||
Total Asset | 805.56 M | |||
Z Score | 3.6 | |||
Annual Yield | 0.01 % | |||
Net Asset | 805.56 M | |||
Last Dividend Paid | 0.95 |
About COSMO Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze COSMO Pharmaceuticals SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of COSMO Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of COSMO Pharmaceuticals SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.